Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYEW.L Regulatory News (YEW)

  • There is currently no data for YEW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

15 Feb 2019 11:30

RNS Number : 2404Q
Yew Grove REIT PLC
15 February 2019
 

15 February 2019

Yew Grove REIT plc

(the "Company" or, together with its subsidiaries, the "Group")

LTIP Option Awards / PDMR Notification

The Board of Yew Grove REIT plc (ticker: Yew) (the "Board") announces that on 15 February 2019, the Company granted Jonathan Laredo, the Company's Chief Executive Officer, Michael Gibbons the Company's Chief Investment Officer and Charles Peach, the Company's Chief Financial Officer, (together the "Executives") options at 1 cent per share over a total of 1,125,000 ordinary shares of €0.01 each in the Company ("Ordinary Shares") pursuant to the Company Long Term Incentive Plan (the "LTIP") pursuant to the 2019 financial year.

 

This is the first grant under the Company LTIP scheme since its Admission to trading on the London and Irish stock Exchanges and is made on the terms disclosed to investors at the time of Admission. The grant is equally divided between each of the Executive Directors so that each one of the Executive Directors is entitled to 375,000 Ordinary Shares subject to the satisfaction of the performance conditions described below.

 

The LTIP is subject to performance conditions under which 1/3 of the grant relates to a total return (defined as the annualised share price assuming the reinvestment of dividends) and where 30% of the award vests if the total return is at least 10% with 100% vesting at an annualised return of 15% and above. The return will be measured over the three years ending 31st December 2021. 1/3 of the grant is measured by reference to the Company Net Asset Value per share at 31st December 2021 with a 30% grant at 110 cents and a 100% grant at 120 cents. The final 1/3 vests on the dividend per share paid in respect of the year ended 31st December 2021 with 30% vesting at 6.0 cents per share and 100% at 7.5 cents and above. In each case the amount of the grant increases at a pre-determined pro-rata basis between 30% at the minimum level up to 100% at the maximum level.

 

The total number of Ordinary Shares over which options were granted on 12 February 2019 represents approximately 1.5 per cent. of the Company's issued share capital.

 

Enquiries:

 

Yew Grove REIT plc

 

Tel: 353 (1) 480 3960

Jonathan Laredo, Chief Executive Officer

 

 

Michael Gibbons, Chief Investment Officer

 

 

Charles Peach, Chief Financial Officer

 

 

 

 

 

Investec Bank plc

 

 

NOMAD & Joint Broker:

David Anderson, Darren Vickers

 

Tel: +44 (0) 20 7597 5970

ESM Advisor & Joint Broker:

Tommy Conway, Eoin Kennedy

 

 

Tel: +353 (1) 421 0000

 

 

Goodbody Stockbrokers

 

 

Joint Broker:

David Kearney, Joe Gill

 

Tel +353 (1) 667 0400

 

 

 

 

Hume Brophy

 

Tel: + 353 (1) 662 4712

 

Media Enquiries

 

yewgrove@humebrophy.com

 

Edel Bach, Karin O'Conor

 

 

 

 

 

 

     

 

Notes to editors:

Yew Grove REIT is an Irish commercial real estate company invested in a diversified portfolio of Irish commercial property, with a particular focus on well-tenanted commercial real estate assets comprising office and industrial assets let to Irish government entities and other state bodies, IDA Ireland supported and other FDI companies, and larger corporates.

 

Further information on the Company can be found on the Company's website at www.ygreit.com

 

 

APPENDIX I

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name 

1. Jonathan Laredo 

2. Charles Peach

3. Michael Gibbons

2

Reason for the notification

a)

Position/status 

1. Chief Executive Officer

2. Chief Financial Officer

3. Chief Investment Officer

b)

Initial notification/Amendment 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Yew Grove REIT plc 

b)

LEI

6354003383UIBIYIJA86

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 Ordinary Shares of €0.01 eachISIN: IE00BDT5KP12

b)

Nature of the transaction

 

Grant of Share Options made in accordance with the Yew Grove REIT plc Long Term Incentive Plan

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. €0.01

2. €0.01

3. €0.01

1. 375,000

2. 375,000

3. 375,000

 

d)

Aggregated information

 

Price(s)

Volume(s)

N/A

N/A

 

e)

Date of the transaction

 

15 February 2019

f)

Place of the transaction 

 

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFFLFRIELIA
Date   Source Headline
30th Jun 20207:00 amRNSLTIP Option Awards / PDMR Notification
29th Jun 202012:24 pmRNSSecond Quarter Dividend
18th Jun 20204:49 pmRNSHolding(s) in Company
5th Jun 20207:00 amRNSRent Collection Update
29th May 20201:09 pmRNSResult of EGM
29th May 20201:02 pmRNSResult of AGM
19th May 202010:18 amRNSUpdate on upcoming General Meetings
28th Apr 202011:27 amRNSAnnual Report and Notice of AGM and EGM
24th Apr 20207:00 amRNSPublication of Annual Report
15th Apr 20207:00 amRNSTrading and Covid-19 Update & Dividend Declaration
6th Apr 20205:00 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSPreliminary Results
3rd Mar 20204:27 pmRNSFacility Increase
13th Feb 202012:06 pmRNSFourth Quarter Dividend
7th Feb 20207:00 amRNSCompletion of Acquisition
31st Jan 20207:00 amRNSFacility Increase
23rd Jan 20202:00 pmRNSChange of Adviser
23rd Jan 20208:38 amRNSDirector Declaration
16th Jan 20203:51 pmRNSHolding(s) in Company
9th Jan 20205:57 pmRNSHolding(s) in Company
20th Dec 20196:08 pmRNSCompletion of acquisition of office building
19th Dec 20192:55 pmRNSAcquisition of portfolio of six office properties
10th Dec 201910:59 amRNSDirector/PDMR Shareholding
10th Dec 201910:58 amRNSDirector/PDMR Shareholding
10th Dec 201910:57 amRNSDirector/PDMR Shareholding
10th Dec 201910:56 amRNSDirector/PDMR Shareholding
10th Dec 201910:56 amRNSDirector/PDMR Shareholding
10th Dec 201910:54 amRNSDirector/PDMR Shareholding
9th Dec 20192:02 pmRNSHolding(s) in Company
6th Dec 20193:20 pmRNSHolding(s) in Company
6th Dec 20198:00 amRNSEuronext Growth Dublin Notice
4th Dec 20193:42 pmRNSResult of Placing
22nd Nov 20197:00 amRNSProposed Placing
11th Nov 20197:00 amRNSSale of non-core property
1st Nov 20197:00 amRNSIDA Ireland Building Acquisition
26th Sep 20194:39 pmRNSThird Quarter Dividend
4th Sep 20191:50 pmRNSInterim Results
19th Jul 20193:30 pmRNSAcquisition of Portfolio
15th Jul 20194:40 pmRNSDirector/PDMR Shareholding
15th Jul 20194:40 pmRNSDirector/PDMR Shareholding
15th Jul 20194:36 pmRNSDirector/PDMR Shareholding
15th Jul 20194:35 pmRNSDirector/PDMR Shareholding
15th Jul 20194:35 pmRNSDirector/PDMR Shareholding
12th Jul 20198:00 amRNSEuronext Growth Dublin Notice
11th Jul 20195:07 pmRNSRevolving Loan Facility Increase
11th Jul 201912:20 pmRNSResult of EGM and Total Voting Rights
26th Jun 20193:05 pmRNSSecond Quarter Interim Dividend Confirmation
18th Jun 201912:00 pmRNSResult of Placing and Notice of EGM
13th Jun 20197:00 amRNSAnnouncement of Share Issuance Programme
29th May 20193:27 pmRNSLease surrender

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.